ClosedSuppliesEuropeanOnderhandeling zonder bekendmaking

Transfemoral tricuspid valve replacement (TTVR).

Stichting Amsterdam UMC · Onderhandeling zonder bekendmaking · 1 lots · 361245
Type
Supplies
33182220
Estimated value
€ 420K
estimated
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

Stichting Amsterdam UMC has opened a tender for the supply of a transfemoral tricuspid valve replacement (TTVR) system. The procedure is conducted via negotiations without prior publication, meaning the contracting authority negotiates directly with selected suppliers without public announcement. TTVR is an advanced medical technology that replaces a tricuspid heart valve via the femoral artery without open-heart surgery. The organization expects a complete package: the implant, associated instruments, training for the surgical team, aftercare, and technical support. Additionally, the product must comply with EU medical device regulations (CE marking, ISO 13485, MDR). The tender focuses on suppliers with proven experience in heart valve technology, a strong quality management system, and a track record in delivering complex medical systems. The delivery terms include rapid availability, warranty, service and maintenance, and a clear pricing structure.

Supplies · Onderhandeling zonder bekendmaking · European procedure

European
Contracting authority
Contract type
Supplies
Onderhandeling zonder bekendmaking
Estimated value
€420,000
estimated value
Submission deadline
Ongoing
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
Location
Netherlands
CharacteristicsCPV 33SuppliesEU tenderTTVRtricuspid valve replacementtransfemoral

01What is being requested

Stichting Amsterdam UMC has opened a tender for the supply of a transfemoral tricuspid valve replacement (TTVR) system. The procedure is conducted via negotiations without prior publication, meaning the contracting authority negotiates directly with selected suppliers without public announcement. TTVR is an advanced medical technology that replaces a tricuspid heart valve via the femoral artery without open-heart surgery. The organization expects a complete package: the implant, associated instruments, training for the surgical team, aftercare, and technical support. Additionally, the product must comply with EU medical device regulations (CE marking, ISO 13485, MDR). The tender focuses on suppliers with proven experience in heart valve technology, a strong quality management system, and a track record in delivering complex medical systems. The delivery terms include rapid availability, warranty, service and maintenance, and a clear pricing structure.

Transfemoral tricuspid valve replacement (TTVR).

33182220€ 420KSupplies
1Transfemoral tricuspid valve replacement (TTVR).

02Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

03Value in context

€420,000

04Likely competitors

#Likely bidderFitWins
1Medtronic Trading NL B.V.SME9530×
2Boston Scientific Nederland B.V.SME8820×
3Abbott Medical Nederland B.V.SME8516×
4Johnson & Johnson Medical B.V.SME7916×
5Edwards Lifesciences B.V.SME78
6LivaNova Nederland N.V.SME75

05Legal themes that may be relevant here

06Frequently asked questions

What is the specific scope of the supply for this contract?
The supply concerns a tricuspid valve for the purpose of transfemoral tricuspid valve replacement (TTVR).

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 317K
median
€ 892K
p75
€ 3,3 mln
€ 420K

Gegunde waarden in CPV 33 · leveringen n=528